Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NTRK2 | Q16620 | 1/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | LIMK2 | P53671 | 2/20 | 0.35 |
| ▸ | CA12 | O43570 | 3/20 | 0.34 |
| ▸ | CA6 | P23280 | 3/20 | 0.34 |
| ▸ | CA7 | P43166 | 3/20 | 0.34 |
| ▸ | CA9 | Q16790 | 3/20 | 0.34 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.34 |
| ▸ | CA5B | Q9Y2D0 | 3/20 | 0.34 |
| ▸ | RECQL | P46063 | 2/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | REN | P00797 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | LMNA | P02545 | 3/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.33 |
| ▸ | CA2 | P00918 | 2/20 | 0.33 |
| ▸ | CA3 | P07451 | 2/20 | 0.33 |
| ▸ | CA4 | P22748 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14519209 | 0.85 | NTRK2 (0.44) | NTRK2LIMK2RECQLALDH1A1LMNA | |
| SCHEMBL18249527 | 0.76 | NTRK2 (0.55) | NTRK2CYP2C19MEN1KMT2AALDH1A1 | |
| SCHEMBL7155724 | 0.74 | NTRK2 (0.40) | NTRK2LIMK2RECQLALDH1A1LMNA | |
| SCHEMBL2781653 | 0.73 | ROCK1 (0.37) | NTRK2CYP2C9CYP2C19LIMK2MEN1 | |
| SCHEMBL19524518 | 0.71 | CA12 (0.41) | CYP2C9CYP2C19CA12CA6CA7 | |
| SCHEMBL19285672 | 0.69 | CES2 (0.50) | — | |
| SCHEMBL14327337 | 0.68 | ADRA2C (0.56) | CYP2C19LIMK2RECQLMEN1KMT2A | |
| SCHEMBL30906970 | 0.68 | CYP2C9 (0.35) | CYP2C9CYP2C19CA12CA6CA7 | |
| Isophthalic Acid SCHEMBL589816 | 0.68 | KDM4E (0.49) | CYP2C9CYP2C19CA12CA6CA9 | |
| SCHEMBL16276206 | 0.68 | ADRA2C (0.51) | NTRK2LIMK2MEN1KMT2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020016451-A1 | SOLUTION PHASE BIOPOLYMER SYNTHESIS | CAPROTEC BIOANALYTICS GMBH (DE) | 2002-02-07 | — | — | US | claimed |
| US-20020007048-A1 | Solution Phase Biopolymer Synthesis | CAPROTEC BIOANALYTICS GMBH (DE) | 2002-01-17 | — | — | US | claimed |
| US-7094943-B2 | Solution phase biopolymer synthesis | Köster, Hubert (US) | 2006-08-22 | — | — | US | disclosed |
| US-7038103-B2 | Solution phase biopolymer synthesis | HUBERT KOSTER (CH) | 2006-05-02 | — | — | US | disclosed |
| US-20020016451-A1 | SOLUTION PHASE BIOPOLYMER SYNTHESIS | CAPROTEC BIOANALYTICS GMBH (DE) | 2002-02-07 | — | — | US | disclosed |
| US-20020007048-A1 | Solution Phase Biopolymer Synthesis | CAPROTEC BIOANALYTICS GMBH (DE) | 2002-01-17 | — | — | US | disclosed |
| EP-1073668-A2 | SOLUTION PHASE BIOPOLYMER SYNTHESIS | Köster, Hubert (US) | 2001-02-07 | — | — | EP | disclosed |
| WO-1999055718-A2 | SOLUTION PHASE BIOPOLYMER SYNTHESIS | KOESTER HUBERT (US) | 1999-11-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020007048-A1 | Solution Phase Biopolymer Synthesis | RNGTT, SGMS1, SPNS2 | NTRK2 3944/4885CYP2C9 4822/4885CYP2C19 4848/4885 |
| US-20020016451-A1 | SOLUTION PHASE BIOPOLYMER SYNTHESIS | RNGTT, SGMS1, SPNS2 | NTRK2 3944/4885CYP2C9 4822/4885CYP2C19 4848/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.